Riskpilot← Back to searchSign inGet full accessMeTa Psykoterapi AB
ABActiveOrg 5593626749Activities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-245% vs 2023
Equity ratio
-109.1%
Financial strength
Net profit 2024
SEK -44K
-267% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -38K | -245% |
| Net profit | SEK -44K | -267% |
| Total assets | SEK 33K | +14% |
| Equity | SEK -36K | -550% |
| Employees | 0 | — |
Legal name
MeTa Psykoterapi AB
Org number
5593626749
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
27 januari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva psykosocial verksamhet med evidensbaserad & kvalificerad samtalsbehandling.
Address
Email
safa@westre.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 37 | 0 |
| Staff expenses | — | −0 | — | — |
| EBITDA | −5 | — | −11 | −38 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −5 | −5 | −11 | −38 |
| Net financials | — | — | −1 | −6 |
| Profit before tax | −5 | — | −12 | −44 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −5 | −5 | −12 | −44 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 30 | 30 | 29 | 33 |
| Equity | 20 | 0 | 8 | −36 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 10 | 21 | 69 |
| Total debt | 10 | 10 | 21 | 69 |
EBITDA margin
-3800000.0%
This company
15.8%
Market median
-24050733% vs market
20222024
Equity ratio
-109.1%
This company
38.2%
Market median
-386% vs market
20222024
Return on equity
-4400000.0%
This company
18.4%
Market median
-23913143% vs market
20222024
Net profit margin
-4400000.0%
This company
8.1%
Market median
-54321088% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
1.92×
This company
0.62×
Market median
-210% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-27 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2026 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MeTa Psykoterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Serop Bengtsson-Kabranian | Board of Directors | 0 companies |
| Jessica V M Bengtsson-Kabranian | Deputy Board Member | 0 companies |
| Safa Allan Parséus | Chairman | 0 companies |
| Serop Bengtsson-Kabranian | Board of Directors | 0 companies |
| Jessica V M Bengtsson-Kabranian | Deputy Board Member | 0 companies |